Liu T, Deng K, Xue Y, Yang R, Yang R, Gong Z, et al
April 15, 2026: In the updated 503A document, the FDA announced it is removing BPC-157 (both BPC-157 acetate and BPC-157 free base) from Category 2 and scheduling a PCAC meeting for July 23, 2026
In biochemical and cellular research models, AOD9604 is used to investigate growth hormonerelated signalling pathways that are independent of classical GH receptor activation
Generally speaking, the absorption efficiency after oral administration may be affected by the gastrointestinal environment, and different physiological states of the gastrointestinal tract may lead to differences in absorption rate and degree
Individuals with significant stubborn fat deposits, particularly visceral abdominal fat, may benefit disproportionately
10.1093/gerona/55.2.B95 52 HandelsmanD